학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 728건 | 목록 1~20
Academic Journal
Mirallas O; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. oriolmirallas@vhio.net.; Ruiz-Pace F; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Velilla G; Neuro-Oncology Unit, Instituto de Investigación 12 de Octubre, Madrid, Spain.; Gómez-Puerto D; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Gorria T; Medical Oncology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain.; Yaringaño J; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martínez-Monino Á; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; López-Valbuena D; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vaz MA; Medical Oncology Department, Hospital Ramón y Cajal, Irycis, Madrid, Spain.; Hernandez A; Medical Oncology Department, Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.; Martínez-Saez E; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Sorolla MA; Medical Oncology, Hospital de de la Santa Creu i Sant Pau, Barcelona, Spain.; Castro-Henriques M; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Bardaji JL; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Di Muzio A; Humanitas University, Milan, Italy.; Gallego O; Medical Oncology, Hospital de de la Santa Creu i Sant Pau, Barcelona, Spain.; Martínez-García M; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Domenech M; Medical Oncology Department, Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.; Carles J; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Balaña C; Medical Oncology Department, Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.; Pineda E; Medical Oncology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain.; Dienstmann R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; University of Vic - Central University of Catalonia, Barcelona, Spain.; Sepúlveda JM; Neuro-Oncology Unit, Instituto de Investigación 12 de Octubre, Madrid, Spain.; Vieito M; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Academic Journal
Spanggaard I; Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen 2100, Denmark.; Matrana M; Ochsner Cancer Institute, Ochsner Clinic Foundation, New Orleans, LA 70121, United States.; Rocha Lima C; Department of Hematology and Oncology, Wake Forest University School of Medicine-Atrium Health, Winston-Salem, NC 27157, United States.; Mahipal A; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States.; Seidman Cancer Center, Case Western Reserve University, Cleveland, OH 44106, United States.; Vieito M; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Hervieu A; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon 21000, France.; Goyal L; Mass General Cancer Center, Harvard Medical School, Boston, MA 02114, United States.; Stanford Cancer Center, Stanford School of Medicine, Stanford, CA 94305, United States.; Rodón J; MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, United States.; Veronese ML; Incyte International Biosciences Sàrl, Morges 1110, Switzerland.; Oliveira N; Incyte International Biosciences Sàrl, Morges 1110, Switzerland.; Li X; Incyte Corporation, Wilmington, DE 19803, United States.; Schaffer M; Incyte Corporation, Wilmington, DE 19803, United States.; Kesari S; Providence Southern California Research Clinical Institute, Saint John's Cancer Institute, Pacific Neuroscience Institute, Los Angeles, CA 90404, United States.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Conference
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Fontana, E, Wang, J, Mckean, M, Aljumaily, R, Machiels, J P, Doger de Spéville, B, Vieito, M, Carter, L, Prenen, H, Falchook, G S, Greystoke, A, Ortuzar Feliu, W I, De, A, Gu, X, Li, M, Rienzo, A D & Bashir, B 2024, '647P EphA2-targeting bicycle toxin conjugate (BTC) BT5528 in patients (pts) with advanced solid tumors: A phase I/II study', Annals of Oncology, vol. 35, pp. S511-S512. https://doi.org/10.1016/j.annonc.2024.08.713
Academic Journal
Navarro-Garcia D; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Grussu F; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Zatse C; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Klümper N; Department of Urology, UKB, Bonn, Germany.; Institute of Experimental Oncology, UKB, Bonn, Germany.; Macarro C; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Hernando-Calvo A; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Sanz M; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Vieito M; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Braña I; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Head & Neck Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Mirallas O; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Alonso G; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Galvao V; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Pretelli G; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Lostes J; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Oberoi A; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Toledo R; Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Garralda E; Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Perez-Lopez R; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain rperez@vhio.net.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Editorial & Opinion
Macarro C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Bernatowicz K; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Garcia-Ruiz A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Serna G; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Monreal-Agüero C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Simonetti S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Figini M; Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.; Corral JF; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Diagnòstic per la Imatge (IDI), Barcelona, Spain.; Garay V; PET/MR Unit, CETIR-Ascires, Barcelona, Spain.; Vidorreta M; Siemens Healthineers, Madrid, Spain.; García-Polo García P; GE HealthCare, Madrid, Spain.; Merino X; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Diagnòstic per la Imatge (IDI), Barcelona, Spain.; Mast R; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Diagnòstic per la Imatge (IDI), Barcelona, Spain.; Roson N; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Diagnòstic per la Imatge (IDI), Barcelona, Spain.; Vieito M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escobar M; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Diagnòstic per la Imatge (IDI), Barcelona, Spain.; Alexander DC; Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.; Toledo R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Perez-Lopez R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Grussu F; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE; In Process
Academic Journal
Pérez-Torres Lobato MR; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.; Morell M; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.; Solano-Páez P; Pediatric Oncology Division, Virgen del Rocio Hospital, Sevilla, Spain.; Ortiz-Palacios M; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.; Menárgez Á; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.; Panesso M; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.; Vázquez-Gómez F; Pediatric Oncology Division, Niño Jesús Hospital, Madrid, Spain.; Moreno-Carrasco J; Pediatric Oncology Division, Niño Jesús Hospital, Madrid, Spain.; Lassaletta Á; Pediatric Oncology Division, Niño Jesús Hospital, Madrid, Spain.; Santa-María V; Pediatric Oncology Division, Pediatric Cancer Center Barcelona, Barcelona, Spain.; Pavon-Mengual M; Pediatric Oncology Division, Pediatric Cancer Center Barcelona, Barcelona, Spain.; Quiroga E; Pediatric Oncology Division, Virgen del Rocio Hospital, Sevilla, Spain.; García-Ariza MA; Pediatric Oncology Division, Cruces University Hospital, Vizcaya, Spain.; Biobizkaia Research Institute, Cruces University Hospital, Vizcaya, Spain.; Mora-Matilla M; Pediatric Oncology Division, Badajoz University Hospital, Badajoz, Spain.; Garrido-Colino C; Pediatric Oncology Division, Gregorio Marañón Hospital, Madrid, Spain.; Verdú-Amoros J; Pediatric Oncology Division, La Fe University Hospital, Valencia, Spain.; Nova-Lozano C; Pediatric Oncology Division, La Fe University Hospital, Valencia, Spain.; Vieito M; Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Cordero-Asanza EX; Department of Neurosurgery, Vall d´Hebrón Hospital, Barcelona, Spain.; Clemente M; Pediatric Endocrinology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Ramos-Albiat M; Department of Radiotherapy, Vall d´Hebrón Hospital, Barcelona, Spain.; de Las Morenas-Iglesias J; Ophthalmology Clinic and Refractive Surgery, Baviera Clinic, Barcelona, Spain.; Moreno L; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.; Llort A; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.
Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Vieito, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어